Display options
Cite
Sorongon-Legaspi MK, Chua M, Sio MC, et al. Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer. 2013;2013:875615doi: 10.1155/2013/875615.
Sorongon-Legaspi, M. K., Chua, M., Sio, M. C., & Morales, M. (2013). Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate cancer, 2013875615. https://doi.org/10.1155/2013/875615
Sorongon-Legaspi, Mishell Kris, et al. "Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer." Prostate cancer vol. 2013 (2013): 875615. doi: https://doi.org/10.1155/2013/875615
Sorongon-Legaspi MK, Chua M, Sio MC, Morales M. Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer. 2013;2013:875615. doi: 10.1155/2013/875615. Epub 2013 Mar 25. PMID: 23589776; PMCID: PMC3621295.
Copy Download .nbib Format: NLM
Share it on

Prostate Cancer. 2013;2013:875615. doi: 10.1155/2013/875615. Epub 2013 Mar 25.

Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer.

Prostate cancer

Mishell Kris Sorongon-Legaspi, Michael Chua, Maria Christina Sio, Marcelino Morales

Affiliations

  1. Department of Preventive and Community Medicine, St. Luke's College of Medicine, Sta. Ignaciana Street, 1102 Quezon City, Philippines.

PMID: 23589776 PMCID: PMC3621295 DOI: 10.1155/2013/875615

Abstract

Previous researches involving dietary methods have shown conflicting findings. Authors sought to assess the association of prostate cancer risk with blood levels of omega-3 polyunsaturated fatty acids (n-3 PUFA) through a meta-analysis of human epidemiological studies in available online databases (July, 2012). After critical appraisal by two independent reviewers, Newcastle-Ottawa Quality Assessment Scale (NOQAS) was used to grade the studies. Six case control and six nested case control studies were included. Results showed nonsignificant association of overall effect estimates with total or advanced prostate cancer or high-grade tumor. High blood level of alpha-linolenic acid (ALA) had nonsignificant positive association with total prostate cancer risk. High blood level of docosapentaenoic acid (DPA) had significant negative association with total prostate cancer risk. Specific n-3 PUFA in fish oil, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) had positive association with high-grade prostate tumor risk only after adjustment of interstudy variability. There is evidence that high blood level of DPA that is linked with reduced total prostate cancer risk and elevated blood levels of fish oils, EPA, and DHA is associated with high-grade prostate tumor, but careful interpretation is needed due to intricate details involved in prostate carcinogenesis and N-3 PUFA metabolism.

References

  1. Int J Cancer. 2007 Jan 15;120(2):398-405 - PubMed
  2. Cancer Causes Control. 2000 Aug;11(7):609-15 - PubMed
  3. BJU Int. 2004 Jun;93(9):1211-5 - PubMed
  4. Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):97-9 - PubMed
  5. Nat Rev Cancer. 2007 Apr;7(4):256-69 - PubMed
  6. J Urol. 2000 Nov;164(5):1570-2 - PubMed
  7. Cancer Causes Control. 2007 Dec;18(10):1107-21 - PubMed
  8. Cancer. 1989 Aug 1;64(3):598-604 - PubMed
  9. Ethn Dis. 2009 Autumn;19(4):454-61 - PubMed
  10. Ann Intern Med. 2009 Aug 18;151(4):264-9, W64 - PubMed
  11. Br J Nutr. 2002 Oct;88(4):355-63 - PubMed
  12. J Clin Invest. 2007 Jul;117(7):1866-75 - PubMed
  13. Br J Cancer. 2008 May 6;98(9):1574-81 - PubMed
  14. Am J Epidemiol. 2005 Aug 15;162(4):373-81 - PubMed
  15. Cancer Causes Control. 2000 Sep;11(8):679-85 - PubMed
  16. Am J Clin Nutr. 2008 May;87(5):1405-13 - PubMed
  17. BJU Int. 2003 Oct;92(6):551-4 - PubMed
  18. Cancer Causes Control. 2006 Aug;17(6):783-91 - PubMed
  19. Prostate Cancer Prostatic Dis. 2006;9(3):230-4 - PubMed
  20. Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):85-91 - PubMed
  21. Lipids. 1992 Nov;27(11):863-9 - PubMed
  22. Am J Epidemiol. 1997 Jun 15;145(12):1114-22 - PubMed
  23. Biometrics. 1994 Dec;50(4):1088-101 - PubMed
  24. Am J Clin Nutr. 2003 Mar;77(3):532-43 - PubMed
  25. Matern Child Nutr. 2011 Oct;7 Suppl 3:44-65 - PubMed
  26. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1364-70 - PubMed
  27. Am J Clin Nutr. 2009 May;89(5):1558S-1564S - PubMed
  28. Am J Clin Nutr. 1997 Dec;66(6 Suppl):1541S-1547S - PubMed
  29. J Natl Cancer Inst. 1994 Feb 16;86(4):281-6 - PubMed
  30. BMJ. 2006 Apr 1;332(7544):752-60 - PubMed
  31. Br J Cancer. 1999 Dec;81(7):1238-42 - PubMed
  32. Am J Epidemiol. 2010 Sep 1;172(5):566-77 - PubMed
  33. Can J Urol. 2008 Feb;15(1):3866-71 - PubMed
  34. Int J Cancer. 2007 Oct 1;121(7):1571-8 - PubMed
  35. Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):161-9 - PubMed
  36. Lipids. 2009 Sep;44(9):827-35 - PubMed
  37. Prostaglandins Leukot Essent Fatty Acids. 1996 Oct;55(4):287-92 - PubMed
  38. Biometrics. 2000 Jun;56(2):455-63 - PubMed
  39. J Nutr. 2008 Feb;138(2):250-6 - PubMed
  40. Cancer Res. 1989 Apr 1;49(7):1857-60 - PubMed
  41. Br J Nutr. 2010 Jan;103(1):32-7 - PubMed
  42. Environ Res. 2005 May;98(1):104-13 - PubMed
  43. Cancer Causes Control. 2007 Feb;18(1):41-50 - PubMed
  44. J Urol. 2005 Sep;174(3):1065-9; discussion 1069-70 - PubMed
  45. Int J Cancer. 1997 May 16;71(4):545-51 - PubMed
  46. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1422-8 - PubMed
  47. Prostaglandins Leukot Essent Fatty Acids. 2003 May;68(5):337-42 - PubMed
  48. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  49. Int J Oncol. 2005 Mar;26(3):785-92 - PubMed
  50. Urol Oncol. 2013 Apr;31(3):318-24 - PubMed
  51. J Urol. 2004 Apr;171(4):1402-7 - PubMed
  52. Ann Surg Oncol. 2007 Dec;14(12):3620-8 - PubMed
  53. J Urol. 2007 Dec;178(6):2391-6; discussion 2396 - PubMed
  54. Curr Opin Gastroenterol. 2005 Mar;21(2):207-15 - PubMed
  55. Prostate. 2001 Jun 1;47(4):262-8 - PubMed
  56. J Urol. 2000 Dec;164(6):2168-72 - PubMed
  57. Am J Clin Nutr. 2001 Oct;74(4):549-54 - PubMed
  58. PLoS Genet. 2011 Jul;7(7):e1002193 - PubMed
  59. Am J Clin Nutr. 2010 Nov;92(5):1040-51 - PubMed
  60. Am J Clin Nutr. 1995 Mar;61(3 Suppl):702S-709S - PubMed
  61. Int J Cancer. 2007 Sep 15;121(6):1339-45 - PubMed
  62. Am J Clin Nutr. 2008 Nov;88(5):1297-303 - PubMed
  63. J Clin Oncol. 2005 Nov 10;23(32):8152-60 - PubMed
  64. Environ Health Perspect. 1999 Aug;107 Suppl 4:639-49 - PubMed
  65. Epidemiology. 1994 May;5(3):276-82 - PubMed
  66. Prostaglandins Leukot Essent Fatty Acids. 2002 May-Jun;66(5-6):467-77 - PubMed
  67. Am J Clin Nutr. 1996 Sep;64(3):305-11 - PubMed
  68. Ai Zheng. 2007 Dec;26(12):1281-6 - PubMed
  69. Ann Oncol. 2005 Jan;16(1):152-7 - PubMed
  70. Cancer Causes Control. 2010 Mar;21(3):347-55 - PubMed
  71. Cancer Causes Control. 2004 Nov;15(9):911-20 - PubMed
  72. Clin Cancer Res. 2009 Apr 1;15(7):2559-66 - PubMed
  73. J Biol Chem. 1984 Dec 10;259(23):14413-7 - PubMed
  74. Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):64-7 - PubMed
  75. Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3577-87 - PubMed
  76. Cancer Causes Control. 2004 May;15(4):367-86 - PubMed
  77. BMJ. 1997 Sep 13;315(7109):629-34 - PubMed
  78. Can Urol Assoc J. 2013 May-Jun;7(5-6):E333-43 - PubMed
  79. Cancer Res. 1990 Nov 1;50(21):6836-40 - PubMed
  80. Public Health Nutr. 2009 May;12(5):609-13 - PubMed
  81. Clin Biochem. 1999 Aug;32(6):405-9 - PubMed
  82. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):889-95 - PubMed
  83. Lancet. 2001 Jun 2;357(9270):1764-6 - PubMed
  84. Neurobiol Aging. 2011 Dec;32(12):2318.e1-15 - PubMed
  85. J Urol. 2000 Sep;164(3 Pt 1):820-5 - PubMed
  86. Am J Clin Nutr. 2010 Nov;92(5):1223-33 - PubMed
  87. Int J Cancer. 2007 Dec 1;121(11):2381-6 - PubMed
  88. Am J Epidemiol. 2011 Jun 15;173(12):1429-39 - PubMed
  89. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):926-7 - PubMed
  90. J Hum Nutr Diet. 2009 Jun;22(3):187-99; quiz 200-2 - PubMed
  91. Int J Cancer. 1997 Aug 7;72(4):587-91 - PubMed
  92. Urology. 2001 Aug;58(2):283-8 - PubMed
  93. CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 - PubMed
  94. J Urol. 2007 Jan;177(1):97-101; discussion 101 - PubMed
  95. Urol Oncol. 2005 Nov-Dec;23(6):390-8 - PubMed
  96. J Nutr. 2007 Jul;137(7):1821-7 - PubMed
  97. J Urol. 2010 Jan;183(1):345-50 - PubMed
  98. Public Health Nutr. 2002 Dec;5(6A):865-71 - PubMed
  99. Am J Clin Nutr. 1997 Dec;66(6 Suppl):1557S-1563S - PubMed
  100. JAMA. 2006 Jan 25;295(4):403-15 - PubMed
  101. Jpn J Cancer Res. 1999 Sep;90(9):914-21 - PubMed
  102. J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):127-47 - PubMed
  103. Actas Urol Esp. 2009 Jul-Aug;33(7):741-6 - PubMed
  104. Reprod Nutr Dev. 2005 Sep-Oct;45(5):581-97 - PubMed
  105. Lipids. 2011 May;46(5):399-407 - PubMed
  106. Cancer Causes Control. 2001 Aug;12(6):557-67 - PubMed
  107. Biochim Biophys Acta. 2006 Apr;1761(4):454-62 - PubMed
  108. Am J Clin Nutr. 2008 Nov;88(5):1353-63 - PubMed
  109. Prostate Cancer. 2012;2012:826254 - PubMed
  110. Am J Clin Nutr. 2004 Jun;79(6):935-45 - PubMed
  111. Cancer. 1999 Sep 15;86(6):1019-27 - PubMed
  112. J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9 - PubMed
  113. Prostate. 2000 Jan;42(1):73-8 - PubMed
  114. Cancer Causes Control. 2011 Jan;22(1):141-50 - PubMed
  115. Hypertension. 2000 Nov;36(5):851-5 - PubMed
  116. J Lipid Res. 2005 Apr;46(4):706-15 - PubMed
  117. BJU Int. 2006 Feb;97(2):270-3 - PubMed
  118. Epidemiol Rev. 1987;9:1-30 - PubMed
  119. Am J Clin Nutr. 2008 Dec;88(6):1618-25 - PubMed
  120. Cancer Causes Control. 2009 Mar;20(2):211-23 - PubMed
  121. Lipids Health Dis. 2005 Apr 13;4:8 - PubMed
  122. Am J Clin Nutr. 2004 Jul;80(1):204-16 - PubMed
  123. Cancer. 2004 Nov 15;101(10 Suppl):2371-490 - PubMed
  124. Am J Epidemiol. 2004 Sep 1;160(5):436-44 - PubMed
  125. J Nutr. 2001 Mar;131(3):828-33 - PubMed
  126. Int J Cancer. 2004 Sep 1;111(3):444-50 - PubMed

Publication Types